wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35005616-BD5696AC-B066-40D1-A75B-A2BD389063FA
Q35005616-BD5696AC-B066-40D1-A75B-A2BD389063FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35005616-BD5696AC-B066-40D1-A75B-A2BD389063FA
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis
P1476
Q35005616-BD5696AC-B066-40D1-A75B-A2BD389063FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35005616-BD5696AC-B066-40D1-A75B-A2BD389063FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f9c5ab1e7fbd68a3109feda4954dc0743e2323cb
P1476
Sorafenib sensitizes solid tum
......
es by the Jak2-Stat3-Mcl1 axis
@en